Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: cross-talk between E3s in the endoplasmic reticulum.

Laboratory of Protein Dynamics and Signaling, Center for Cancer Research, National Cancer Institute, NCI, Frederick 21702, USA.
There are an increasing number of ubiquitin ligases (E3s) implicated in endoplasmic reticulum (ER)-associated degradation (ERAD) in mammals. The two for which the greatest amount of information exists are the RING finger proteins gp78 and Hrd1, which are the structural orthologs of the yeast ERAD E3 Hrd1p. We now report that Hrd1, also known as synoviolin, targets gp78 for proteasomal degradation independent of the ubiquitin ligase activity of gp78, without evidence of a reciprocal effect. This degradation is observed in mouse embryonic fibroblasts lacking Hrd1, as well as with acute manipulation of Hrd1. The significance of this is underscored by the diminished level of a gp78-specific substrate, Insig-1, when Hrd1 expression is decreased and gp78 levels are consequently increased. These finding demonstrate a previously unappreciated level of complexity of the ubiquitin system in ERAD and have potentially important ramifications for processes where gp78 is implicated including regulation of lipid metabolism, metastasis, cystic fibrosis and neurodegenerative disorders.
Mesh Terms:
Animals, Cell Line, Endoplasmic Reticulum, Humans, Mice, Proteasome Endopeptidase Complex, Receptors, Autocrine Motility Factor, Receptors, Cytokine, Ubiquitin-Protein Ligases, Ubiquitination
Biochem. Biophys. Res. Commun. Dec. 18, 2009; 390(3);758-62 [PUBMED:19835843]
Switch View:
  • PTM Genes (1)